Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Federal Trade Commission
Fuji
Express Scripts
Johnson and Johnson
Argus Health
Colorcon
Julphar
Baxter

Generated: December 18, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Dutasteride; Tamsulosin Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00090103 Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment Completed GlaxoSmithKline Phase 3 This study will investigate the efficacy and safety of treatment with dutasteride and tamsulosin, administered once daily for 4 years, alone and in combination, on the improvement of symptoms and clinical outcome in men with moderate to severe symptomatic Benign Prostatic Hyperplasia (BPH). Study visits are every 3 months for up to 4 years (18 clinic visits). Transrectal ultrasound (TRUS) is done annually.
NCT00244309 Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer Completed GlaxoSmithKline Phase 3 The purpose of this study is to determine whether a drug named tamsulosin (Flomax), or another drug named dutasteride (Avodart), or a combination of these two drugs is effective in improving urinary symptoms and decreasing the rate of intermittent self-catheterization after prostate brachytherapy.
NCT00244309 Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer Completed Case Comprehensive Cancer Center Phase 3 The purpose of this study is to determine whether a drug named tamsulosin (Flomax), or another drug named dutasteride (Avodart), or a combination of these two drugs is effective in improving urinary symptoms and decreasing the rate of intermittent self-catheterization after prostate brachytherapy.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Dutasteride; Tamsulosin Hydrochloride

Condition Name

Condition Name for Dutasteride; Tamsulosin Hydrochloride
Intervention Trials
Prostatic Hyperplasia 13
Benign Prostatic Hyperplasia 4
Urologic Diseases 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Dutasteride; Tamsulosin Hydrochloride
Intervention Trials
Prostatic Hyperplasia 17
Hyperplasia 17
Urologic Diseases 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Dutasteride; Tamsulosin Hydrochloride

Trials by Country

Trials by Country for Dutasteride; Tamsulosin Hydrochloride
Location Trials
United States 41
Germany 31
Italy 20
United Kingdom 12
France 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Dutasteride; Tamsulosin Hydrochloride
Location Trials
Maryland 3
Indiana 3
Ohio 2
New York 2
Texas 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Dutasteride; Tamsulosin Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Dutasteride; Tamsulosin Hydrochloride
Clinical Trial Phase Trials
Phase 4 4
Phase 3 5
Phase 1 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Dutasteride; Tamsulosin Hydrochloride
Clinical Trial Phase Trials
Completed 16
Terminated 2
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Dutasteride; Tamsulosin Hydrochloride

Sponsor Name

Sponsor Name for Dutasteride; Tamsulosin Hydrochloride
Sponsor Trials
GlaxoSmithKline 18
Dr. J. Curtis Nickel 1
University of California, Los Angeles 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Dutasteride; Tamsulosin Hydrochloride
Sponsor Trials
Industry 18
Other 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Dow
Covington
Boehringer Ingelheim
Cantor Fitzgerald
Baxter
UBS
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.